DABUR INDIA LTD.

Dabur India Ltd has issued a statement clarifying that its subsidiary, Dabur Nepal Private Limited, has not been impacted by the flash floods that occurred near the Nepal-Tibet border on August 26, 2026. The subsidiary's major operations and manufacturing plants are located in the valley region of Kathmandu and Birganj, which were not affected. Operations of only three distributors in the flood-affected area may experience minor impacts. The overall estimated impact on Dabur India is considered negligible. The company will provide further updates if any material changes occur.

Dabur India Ltd has provided an update regarding an FSSAI order dated August 3, 2026, which prohibited the use of "100%" on certain food products. Initially, the Delhi High Court granted a stay on this order on August 7, 2026. In a subsequent hearing on August 24, 2026, the Hon'ble Delhi High Court has re-notified the matter for December 16, 2026. The existing stay granted by the court remains in effect until the next hearing. Dabur India will inform stock exchanges of any material updates.

Dabur India Limited has announced that the National Company Law Tribunal (NCLT), New Delhi Bench, has reserved its order for the second motion petition concerning the proposed Scheme of Amalgamation between Sesa Care Private Limited (Transferor Company) and Dabur India Limited (Transferee Company). The statutory authorities have also conveyed their no-objection to the scheme. Dabur India will notify stock exchanges upon receiving the formal order. This development follows previous intimations regarding the amalgamation process under the Companies Act, 2013.

Dabur India Ltd has been assigned an ESG Rating of "63" by ESG Risk Assessments and Insights Limited, categorizing the company's performance as "Strong". This rating reflects the company's standing on Environmental, Social, and Governance parameters. Notably, the rating was prepared independently by the agency based on publicly available data, and Dabur India did not engage the agency for this assessment. The rating is now available on Dabur India's website.

Dabur India Ltd announced at its 51st Annual General Meeting (AGM) held on August 06, 2026, the re-appointment of Mr. Rajiv Mehrishi as Non-Executive Independent Director for a second term of five years, effective September 01, 2026, to August 31, 2031. The AGM also approved a modification to the tenure of Mr. Mukesh Hari Butani's second term as Non-Executive Independent Director, shortening it to one year from January 01, 2026, to December 31, 2026. Additionally, Mr. Saket Burman was re-appointed as a Non-Executive Director. These decisions were approved by the shareholders.

Dabur India Ltd has received a significant update regarding a prohibitory order from the Food Safety and Standards Authority of India (FSSAI). The FSSAI order, dated August 3, 2026, had prohibited the use of "100%" in some of Dabur's food products and restricted their sale. However, the company announced on August 7, 2026, that the Hon'ble Delhi High Court has granted a stay against this FSSAI order. This means the prohibitory order is temporarily suspended, allowing Dabur to continue using "100%" in its product claims and sell the affected products, pending further legal proceedings. The company will provide material updates as they become available.

Dabur India Ltd has received a Warning Letter from the United States Food & Drug Administration (US FDA) concerning its manufacturing plant in Silvassa. The letter follows an inspection that identified gaps in data integrity and maintenance. The US FDA had previously issued an Import Alert (IA) 66-40 on June 10, 2026, for drugs manufactured at this plant. Dabur India has been actively engaging with the US FDA, providing updates on its corrective and preventive action plan, with substantial mitigating actions already completed, including data integrity training and infrastructure gap closure. The issue pertains to a small part of the plant related to private label product exports, which do not generate significant revenue, and domestic products remain unaffected. The plant continues to operate for the domestic market.

Dabur India Ltd has disclosed that it received audit observations from the Superintendent, CGST, Audit Circle-6, Ghaziabad, following a GST audit. The observations pertained to ineligible Input Tax Credit (ITC) and other miscellaneous issues for FY 2020-21 to FY 2023-24. Consequently, the company has paid a penalty amount of ₹25,38,726/-. Dabur India stated that this payment has no other impact on the financial operations or other activities of the company.

Dabur India has responded to a news item regarding FSSAI's ban on '100%' claims for its coconut water. The company stated that its product labels comply with legal frameworks and industry practices, and it does not make misleading claims. Dabur confirmed receiving a prohibitory order from FSSAI on August 3, 2026, concerning the '100% Pure' claim on one product. While exploring legal options, Dabur has already begun transitioning to new labels without the '100%' claim. The company asserts that the FSSAI notice does not question the quality, safety, or purity of its products, and the impact is limited to the specific products mentioned. Dabur maintains its commitment to high standards and will continue constructive engagement with FSSAI.

Dabur India Ltd has issued a clarification regarding a news item about FSSAI banning '100%' claims on its honey coconut water. The company stated that its product labels comply with legal frameworks and industry practices, and it has never made misleading claims. Dabur confirmed receiving a prohibitory order from FSSAI on August 3, 2026, concerning the '100% Pure' claim on one product. The company is transitioning labels to new ones without the '100%' claim and is engaging constructively with FSSAI. Dabur maintains that the quality and safety of its products are not questioned, and the impact is limited to the specific products mentioned.